-
1
-
-
84875712743
-
Surgery for NSCLC in the era of personalized medicine
-
Mitsudomi T, Suda K, Yatabe Y. Surgery for NSCLC in the era of personalized medicine. Nat Rev Clin Oncol 2013;10:235-44.
-
(2013)
Nat Rev Clin Oncol
, vol.10
, pp. 235-244
-
-
Mitsudomi, T.1
Suda, K.2
Yatabe, Y.3
-
2
-
-
84863230117
-
A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing
-
Ju YS, Lee WC, Shin JY, et al. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res 2012;22:436-45.
-
(2012)
Genome Res
, vol.22
, pp. 436-445
-
-
Ju, Y.S.1
Lee, W.C.2
Shin, J.Y.3
-
3
-
-
84857929267
-
KIF5B-RET fusions in lung adenocarcinoma
-
Kohno T, Ichikawa H, Totoki Y, et al. KIF5B-RET fusions in lung adenocarcinoma. Nat Med 2012;18:375-7.
-
(2012)
Nat Med
, vol.18
, pp. 375-377
-
-
Kohno, T.1
Ichikawa, H.2
Totoki, Y.3
-
4
-
-
84857985225
-
RET, ROS1 and ALK fusions in lung cancer
-
Takeuchi K, Soda M, Togashi Y, et al. RET, ROS1 and ALK fusions in lung cancer. Nat Med 2012;18:378-81.
-
(2012)
Nat Med
, vol.18
, pp. 378-381
-
-
Takeuchi, K.1
Soda, M.2
Togashi, Y.3
-
5
-
-
84862776857
-
Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
-
Lipson D, Capelletti M, Yelensky R, et al. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med 2012;18:382-4.
-
(2012)
Nat Med
, vol.18
, pp. 382-384
-
-
Lipson, D.1
Capelletti, M.2
Yelensky, R.3
-
6
-
-
84870337408
-
Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad
-
Matsubara D, Kanai Y, Ishikawa S, et al. Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad. J Thorac Oncol 2012;7:1872-6.
-
(2012)
J Thorac Oncol
, vol.7
, pp. 1872-1876
-
-
Matsubara, D.1
Kanai, Y.2
Ishikawa, S.3
-
7
-
-
84880749878
-
Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo
-
Suzuki M, Makinoshima H, Matsumoto S, et al. Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo. Cancer Sci 2013;104:896-903.
-
(2013)
Cancer Sci
, vol.104
, pp. 896-903
-
-
Suzuki, M.1
Makinoshima, H.2
Matsumoto, S.3
-
8
-
-
84878858856
-
Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas
-
Drilon A, Wang L, Hasanovic A, et al. Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas. Cancer Discov 2013;3:630-5.
-
(2013)
Cancer Discov
, vol.3
, pp. 630-635
-
-
Drilon, A.1
Wang, L.2
Hasanovic, A.3
-
9
-
-
84876383602
-
A patient with lung adenocarcinoma and RET fusion treated with vandetanib
-
Gautschi O, Zander T, Keller FA, et al. A patient with lung adenocarcinoma and RET fusion treated with vandetanib. J Thorac Oncol 2013;8:e43-4.
-
(2013)
J Thorac Oncol
, vol.8
, pp. e43-e44
-
-
Gautschi, O.1
Zander, T.2
Keller, F.A.3
-
10
-
-
84870748688
-
RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer
-
Wang R, Hu H, Pan Y, et al. RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer. J Clin Oncol 2012;30:4352-9.
-
(2012)
J Clin Oncol
, vol.30
, pp. 4352-4359
-
-
Wang, R.1
Hu, H.2
Pan, Y.3
-
11
-
-
84886787498
-
RET fusion gene: Translation to personalized lung cancer therapy
-
[Epub ahead of print]
-
Kohno T, Tsuta K, Tsuchihara K, et al. RET fusion gene: Translation to personalized lung cancer therapy. Cancer Sci 2013. [Epub ahead of print].
-
(2013)
Cancer Sci
-
-
Kohno, T.1
Tsuta, K.2
Tsuchihara, K.3
|